The Changing Treatment Paradigm for IgAN
Clinicians have a growing number of options for treating immunoglobulin A nephropathy.
Diagnosis & Disease Information
CD19-CAR T Cell Therapy Fast Tracked for Systemic Lupus Erythematosus
CABA-201 is a 4-1BB-containing fully human CD19-CAR T cell therapy.
Belimumab Approval Expanded to Include Pediatric Lupus Nephritis
The FDA has expanded the approval of belimumab to include pediatric patients 5 to 17 years of age with active lupus nephritis.
Tavneos Approved for ANCA-Associated Vasculitis
The approval was based on data from the phase 3 ADVOCATE trial, which evaluated Tavneos in 330 adults with newly diagnosed or relapsed ANCA-associated vasculitis.
- Loading...
Loading...
Next post in Nephrology
Loading... 
Loading...